Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
65
IBEX Quote, Financials, Valuation and Earnings
Last price:
$37.25
Seasonality move
:
4.47%
Day range:
$38.11 - $38.73
52-week range:
$20.18 - $42.99
Dividend yield:
0%
P/E ratio:
13.75x
P/S ratio:
0.99x
P/B ratio:
3.58x
Volume:
68.9K
Avg. volume:
83.6K
1-year change:
77.66%
Market cap:
$514.2M
Revenue:
$558.3M
EPS (TTM):
$2.78
Analysts' Opinion
-
Consensus RatingIBEX Ltd. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $41.00, IBEX Ltd. has an estimated upside of 7.39% from its current price of $38.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $40.00 representing 100% downside risk from its current price of $38.18.
Fair Value
-
According to the consensus of 2 analysts, IBEX Ltd. has 7.39% upside to fair value with a price target of $41.00 per share.
IBEX vs. S&P 500
-
Over the past 5 trading days, IBEX Ltd. has overperformed the S&P 500 by 0.08% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
IBEX Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
IBEX Ltd. has grown year-over-year revenues for 6 quarters straight. In the most recent quarter IBEX Ltd. reported revenues of $151.2M.
Earnings Growth
-
IBEX Ltd. has grown year-over-year earnings for 6 quarters straight. In the most recent quarter IBEX Ltd. reported earnings per share of $0.82.
Enterprise value:
558M
EV / Invested capital:
--
Price / LTM sales:
0.99x
EV / EBIT:
10.49x
EV / Revenue:
0.96x
PEG ratio (5yr expected):
0.29x
EV / Free cash flow:
17.89x
Price / Operating cash flow:
18.35x
Enterprise value / EBITDA:
7.92x
Gross Profit (TTM):
$160.3M
Return On Assets:
14.62%
Net Income Margin (TTM):
7.14%
Return On Equity:
30.33%
Return On Invested Capital:
19.31%
Operating Margin:
9.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $520M | $513.7M | $579.7M | $129.7M | $151.2M | |
| Gross Profit | $132.8M | $136.5M | $160.3M | $35.3M | $40.2M | |
| Operating Income | $42.7M | $40.5M | $53.2M | $9.1M | $13.7M | |
| EBITDA | $69.7M | $59.3M | $70.4M | $13.5M | $18.1M | |
| Diluted EPS | $1.32 | $1.89 | $2.78 | $0.43 | $0.82 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $147.2M | $142.7M | $167.5M | $188.5M | $152.8M | |
| Total Assets | $287.4M | $279.5M | $295.5M | $306.3M | $283.9M | |
| Current Liabilities | $115.9M | $97.6M | $73.7M | $77.8M | $84M | |
| Total Liabilities | $204M | $176.1M | $139.4M | $135.2M | $140.2M | |
| Total Equity | $83.5M | $103.4M | $156M | $171.1M | $143.6M | |
| Total Debt | $114.9M | $88.9M | $62M | $54.3M | $52.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $45M | $35M | $53.6M | $7.8M | $15.7M | |
| Cash From Investing | -$17.5M | -$10.4M | -$22.4M | -$3.6M | -$7.6M | |
| Cash From Financing | -$7.9M | -$24.4M | -$70.7M | -$4.6M | -$647K | |
| Free Cash Flow | $27.5M | $24.5M | $31.2M | $4.1M | $8M | |
IBEX
Sector
Market Cap
$514.2M
$486.6M
Price % of 52-Week High
88.81%
79.79%
Dividend Yield
0%
0%
Shareholder Yield
12.82%
1.52%
1-Year Price Total Return
77.66%
--
Beta (5-Year)
0.649
0.534
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$38.52
200-day SMA
Buy
Level
$31.55
Bollinger Bands (100)
Buy
Level
31.81 - 39.63
Chaikin Money Flow
Sell
Level
-28K
20-day SMA
Buy
Level
$37.60
Relative Strength Index (RSI14)
Buy
Level
56.25
ADX Line
Buy
Level
26.32
Williams %R
Neutral
Level
-42.1725
50-day SMA
Buy
Level
$36.84
MACD (12, 26)
Buy
Level
0.64
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
14.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6323)
Buy
CA Score
(Annual)
Level (1.1509)
Buy
Beneish M-Score
(Annual)
Level (-2.3988)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.1771)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
IBEX Ltd. is a business process outsourcing company, which engages in technology-enabled customer lifecycle experience solutions. It also specializes in digital marketing, lead generation, online sales, optimization, lead conversion, customer service, billing support, technical support, multi-lingual, omni-channel, retention, renewals, up and cross sell, and win-backs. The company was founded in 1984 and is headquartered in Washington, DC.
Stock Forecast FAQ
In the current month, IBEX has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The IBEX average analyst price target in the past 3 months is $41.00.
-
Where Will IBEX Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that IBEX Ltd. share price will rise to $41.00 per share over the next 12 months.
-
What Do Analysts Say About IBEX Ltd.?
Analysts are divided on their view about IBEX Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IBEX Ltd. is a Sell and believe this share price will drop from its current level to $40.00.
-
What Is IBEX Ltd.'s Price Target?
The price target for IBEX Ltd. over the next 1-year time period is forecast to be $41.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is IBEX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for IBEX Ltd. is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of IBEX?
You can purchase shares of IBEX Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IBEX Ltd. shares.
-
What Is The IBEX Ltd. Share Price Today?
IBEX Ltd. was last trading at $37.25 per share. This represents the most recent stock quote for IBEX Ltd.. Yesterday, IBEX Ltd. closed at $38.18 per share.
-
How To Buy IBEX Ltd. Stock Online?
In order to purchase IBEX Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get IBEX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBEX
Sector
P/E ratio
13.75x
19.19x
PEG ratio
0.29x
0.18x
P/B ratio
3.58x
1.69x
Price / LTM sales
0.99x
0.85x
Growth Metrics
IBEX
Sector
Revenue growth
16.55%
5.01%
Earnings growth
91.43%
5.65%
Revenue (5-year growth)
6.62%
4.27%
Earnings forecast
$0.79
$0.35
Profitability
IBEX
Sector
Profitability FY 2025
$155.4M
$252.3M
Return on invested capital
19.31%
4.72%
Return on assets
14.62%
3.09%
Return on equity
30.33%
8.11%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
5
Balance Sheet
IBEX
Sector
Total cash
$22.7M
$138.8M
Short term investments
--
$32.3M
Total assets
$277.5M
$1.4B
Long term debt
$52.3M
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.63% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
